-89%

est. 2Y upside i

HealthcareSeed

Rank

#1628

Sector

HealthTech

Est. Liquidity

~5Y

Data Quality

Data: Medium

Tortus presents a moderate upside opportunity driven by a large market, strong early traction, and a compelling product, but this is tempered by significant incumbent competition and the inherent risks of an early-stage company.

Last updated: February 23, 2026

Bull (25%)+300%

Tortus achieves significant market penetration, successfully fends off incumbent threats, and expands rapidly into new healthcare systems and geographies, leading to a successful Series B/C round at a much higher valuation or an attractive acquisition.

Base (35%)+50%

Tortus continues to grow steadily within the UK NHS, secures additional funding, but faces ongoing competitive pressure and slower-than-anticipated expansion, resulting in a modest valuation increase.

Bear (40%)-80%

Dominant incumbents like Microsoft or Oracle capture significant market share, Tortus struggles with scaling regulatory compliance, or fails to secure sufficient follow-on funding, leading to a down round or unfavorable acquisition.

Est. time to liquidity~5.0 years

Preference Stack Risk

moderate

Based on an assumed current valuation of $60M (as the actual valuation is not publicly disclosed), investors hold $9M in liquidation preferences, meaning in an exit at or below $60M, common shareholders would receive proceeds only after the first $9M is distributed to preferred shareholders.

Dilution Risk

high

As an early-stage company, Tortus will likely require several more funding rounds (Series B, C, etc.) before a liquidity event, which will lead to significant dilution for common shareholders.

Secondary Liquidity

none

Given its early stage, there is currently no active secondary market for Tortus equity, meaning employees cannot easily sell their shares before a liquidity event.

Partnerships Squad — 2 roles

Engineering — 1 role

Foundation Squad — 1 role

View all 6 open roles at Tortus →

Last updated: February 22, 2026

Community

Valuation Sentiment

Our model estimates -89% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.